Next Treatments
Back to Eczema

IBI356

TypeInjection StagePhase 2 Latest updateDec 31, 2025Phase 2 study started

History

Earliest recorded event: Jan 5, 2024. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Dec 31, 2025Phase 2 trial startedA Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07330934
  • Aug 20, 2025Phase 1 trial completedA First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients ClinicalTrials.gov NCT06193434
  • Jan 5, 2024Phase 1 trial startedA First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients ClinicalTrials.gov NCT06193434

Sources

Trials